Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

BB MEDTECH AG · Küsnacht, Zürich Switzerland ·(Swiss: MED)

Company Description

Seestrasse 16
Küsnacht, Zürich
8700
Switzerland (Map)
Phone: +41-44-267-67-00
Fax: +41-44-267-67-01
    View BB MEDTECH AG Locations On A US MapThis link will open in a new window
    BB MEDTECH is counting on consumers needing more than an apple a day to stay healthy. The Swiss investment company invests in mid-sized public and private companies involved in the global medical technology industry. BB MEDTECH focuses on business sectors such as molecular diagnostics, critical care, dialysis and infusion, ophthalmology, and lab automation. It has invested in companies including Celera, Epigenomics, Carl Zeiss Meditec, and Axis-Shield. Physicians, scientists, and financial professionals at Bellevue Asset Management Group pursue investment opportunities on behalf of BB MEDTECH. The firm was founded in 1995. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key BB MEDTECH AG Financials

    Company TypePublic - Swiss: MED

    Headquarters
    Fiscal Year-EndDecember
    2008 Sales (mil.)$69.9

    BB MEDTECH AG Executives

    2 executives listed for BB MEDTECH AG's Küsnacht, Zürich location.
    TitleName & BioContact
    PresidentHeino von ProndzynskiNetwork
    VPWolfgang ReimNetwork

    Competition

    Competitive Landscape for BB MEDTECH AG
    Demand is driven primarily by the pace of technological innovation and the number of companies created to commercialize new technologies. The profitability of individual companies depends on successfully choosing and managing a portfolio of investments. Large companies have advantages in attracting investors, developing expertise in multiple technology markets, and funding large deals. Small companies can compete effectively by concentrating on specific market sectors or geographic areas. The average venture capital investment is about $8 million. Individual, or angel, investors, and large companies with strategic interests in early-stage companies are also sources of new venture funding. To read the full description, subscribe now.
    Top BB MEDTECH AG Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!